Guangdong Marubi Biotechnology Co., Ltd. (603983.SS)
CNY 41.44
(5.04%)
CNY 41.44
(5.04%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 259.41 Million CNY | 48.93% |
| 2022 | 174.18 Million CNY | -29.74% |
| 2021 | 247.92 Million CNY | -46.61% |
| 2020 | 464.39 Million CNY | -9.81% |
| 2019 | 514.88 Million CNY | 23.99% |
| 2018 | 415.27 Million CNY | 33.14% |
| 2017 | 311.91 Million CNY | 34.34% |
| 2016 | 232.18 Million CNY | -17.5% |
| 2015 | 281.43 Million CNY | 3.71% |
| 2014 | 271.37 Million CNY | 24.13% |
| 2013 | 218.61 Million CNY | 16.98% |
| 2012 | 186.87 Million CNY | 11.73% |
| 2011 | 167.25 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 65.9 Million CNY | -40.42% |
| 2024 Q1 | 110.62 Million CNY | 29.25% |
| 2024 Q3 | 62.26 Million CNY | -5.53% |
| 2023 Q3 | 43.14 Million CNY | -17.05% |
| 2023 Q2 | 52.01 Million CNY | -33.88% |
| 2023 Q1 | 78.66 Million CNY | 45.22% |
| 2023 FY | 259.41 Million CNY | 48.93% |
| 2023 Q4 | 85.58 Million CNY | 98.38% |
| 2022 Q4 | 54.17 Million CNY | 3757.84% |
| 2022 Q3 | 1.4 Million CNY | -97.28% |
| 2022 Q1 | 65.47 Million CNY | -38.18% |
| 2022 Q2 | 51.59 Million CNY | -21.2% |
| 2022 FY | 174.18 Million CNY | -29.74% |
| 2021 Q3 | -47.14 Million CNY | -152.96% |
| 2021 FY | 247.92 Million CNY | -46.61% |
| 2021 Q1 | 100.12 Million CNY | -20.81% |
| 2021 Q2 | 89.02 Million CNY | -11.09% |
| 2021 Q4 | 105.91 Million CNY | 324.66% |
| 2020 Q2 | 149.28 Million CNY | 25.61% |
| 2020 Q3 | 69.83 Million CNY | -53.22% |
| 2020 FY | 464.39 Million CNY | -9.81% |
| 2020 Q4 | 126.43 Million CNY | 81.05% |
| 2020 Q1 | 118.84 Million CNY | -23.72% |
| 2019 Q3 | 102.74 Million CNY | -24.53% |
| 2019 Q1 | 120.21 Million CNY | -33.01% |
| 2019 FY | 514.88 Million CNY | 23.99% |
| 2019 Q4 | 155.79 Million CNY | 51.63% |
| 2019 Q2 | 136.13 Million CNY | 13.25% |
| 2018 Q2 | 98.88 Million CNY | 3.05% |
| 2018 FY | 415.27 Million CNY | 33.14% |
| 2018 Q4 | 179.43 Million CNY | 337.69% |
| 2018 Q3 | 40.99 Million CNY | -58.54% |
| 2018 Q1 | 95.95 Million CNY | 0.0% |
| 2017 FY | 311.91 Million CNY | 34.34% |
| 2016 FY | 232.18 Million CNY | -17.5% |
| 2015 FY | 281.43 Million CNY | 3.71% |
| 2014 FY | 271.37 Million CNY | 24.13% |
| 2013 FY | 218.61 Million CNY | 16.98% |
| 2012 FY | 186.87 Million CNY | 11.73% |
| 2011 FY | 167.25 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Liuzhou Liangmianzhen Co., Ltd. | 22.8 Million CNY | -1037.466% |
| Shanghai Jahwa United Co., Ltd. | 500.04 Million CNY | 48.122% |
| Henan Rebecca Hair Products Co., Ltd. | 12.3 Million CNY | -2008.699% |
| Perfect Group Corp., Ltd | 92.51 Million CNY | -180.41% |
| RUNBEN BIOTECHNOLOGY | 226.02 Million CNY | -14.773% |
| Proya Cosmetics Co.,Ltd. | 1.19 Billion CNY | 78.271% |
| Lafang China Co.,Ltd | 65.49 Million CNY | -296.064% |
| Shanghai Flyco Electrical Appliance Co., Ltd. | 1.01 Billion CNY | 74.558% |
| Hangzhou Haoyue Personal Care Co., Ltd | 438.59 Million CNY | 40.853% |